Compare Medical Cannabis Payment Solutions (REFG) With Other Cannabis Stocks
Head-to-head stock comparisons across price, valuation, financials, and growth metrics
Medical Cannabis Payment Solutions (REFG)
$29.28
+1.96%
$335.6M
Ancillary
Ancillary Sector Peers
All Ancillary cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.
| Ticker | Name | Price | Change % | MCap |
|---|---|---|---|---|
| SMG | Scotts Miracle-Gro | $63.23 | +0.57% | $3.55B |
| TPB | Turning Point Brands | $74.39 | -0.05% | $1.44B |
| AGFY | Agrify Corp | $47.12 | +4.71% | $94.2M |
| MAPS | WM Technology (Weedmaps) | $0.69 | +2.60% | $73.4M |
| GRWG | GrowGeneration | $1.09 | +1.75% | $65.5M |
| FORA | Forian Inc | $2.09 | 0.00% | $63.7M |
| GRAMF | TPCO Holding (The Parent Company) | $0.16 | -12.99% | $45.7M |
| HYFM | Hydrofarm Holdings | $1.02 | 0.00% | $4.8M |
| FNNZF | FinCanna Capital | $0.00 | +38.10% | $545.2K |
Top Matchups by Market Cap
Companies closest to Medical Cannabis Payment Solutions in market capitalization — the most meaningful head-to-head comparisons.
Cross-Sector Comparisons
Top cannabis companies outside the Ancillary sector. Compare across different business models and market segments.
Jazz Pharmaceuticals
MCap: $11.60B
Curaleaf Holdings
MCap: $1.80B
Green Thumb Industries
MCap: $1.54B
Innovative Industrial Properties
MCap: $1.39B
Trulieve Cannabis
MCap: $1.22B
Comparing REFG in the Cannabis Market
Medical Cannabis Payment Solutions (REFG) is a Ancillary-sector cannabis company trading at $29.28 per share with a market capitalization of $335.6M. Among its Ancillary peers, REFG ranks #3 by market cap, with trailing twelve-month revenue of $1.95B and a gross margin of 8.5%. The stock has moved +1.96% in the current session, trading on the OTC exchange.
When comparing REFG against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (13.2x), revenue growth (-28.70% YoY), and balance sheet strength (cash of $302.5M vs. debt of $569.6M). The comparison tables above allow you to evaluate Medical Cannabis Payment Solutions relative to 9 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.
Frequently Asked Questions
How does REFG compare to other Ancillary stocks?+
What is REFG's biggest competitor?+
Is REFG overvalued compared to its peers?+
Which cannabis stock has better margins than REFG?+
Can I compare REFG to stocks in other cannabis sectors?+
All REFG Comparisons
Every available head-to-head comparison for Medical Cannabis Payment Solutions.
Related Pages
Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.